CRISPR Therapeutics (CRSP +3.6%) has received a grant from the Bill & Melinda Gates Foundation to research in vivo gene editing therapies for the ...
Source link
CRISPR Therapeutics (CRSP +3.6%) has received a grant from the Bill & Melinda Gates Foundation to research in vivo gene editing therapies for the ...
Source link